GCDFP-15/PIP Polyclonal antibody
GCDFP-15/PIP Polyclonal Antibody for IHC,ELISA
Host / Isotype
Rabbit / IgG
Cat no : 16068-1-AP
Validation Data Gallery
|Positive IHC detected in
|human breast cancer tissue, human skin tissue, human breast tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|IHC : 1:200-1:800
|It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
|Sample-dependent, check data in validation data gallery
16068-1-AP targets GCDFP-15/PIP in IHC,ELISA applications and shows reactivity with human samples.
|Host / Isotype
|Rabbit / IgG
|GCDFP-15/PIP fusion protein Ag9004
|Calculated molecular weight
|146 aa, 17 kDa
|GenBank accession number
|Gene ID (NCBI)
|Antigen affinity purification
|PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
|Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.
GCDFP-15 (gross cystic disease fluid protein 15), also known as PIP (prolactin-induced protein) is a secretory glycoprotein expressed in benign and malignant breast tumor tissues and in some normal exocrine organs such as sweat, salivary, and lacrimal glands (PMID: 12393800). GCDFP-15 expression is increased by prolactin and androgen and inhibited by estrogen (PMID: 18854942). The expression is also regulated by interleukins. GCDFP-15 is a marker of apocrine differentiation and is frequently used for assessment of metastases or regional recurrences of breast origin.